China SXT Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SXTC and other ETFs, options, and stocks.

About SXTC

China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). Its product categories include directly-oral, after-soaking-oral, fine, and regular TCMP. 

CEO
Feng Zhou
CEOFeng Zhou
Employees
75
Employees75
Headquarters
Taizhou, Jiangsu
HeadquartersTaizhou, Jiangsu
Founded
2005
Founded2005
Employees
75
Employees75

SXTC Key Statistics

Market cap
11.68M
Market cap11.68M
Price-Earnings ratio
-0.41
Price-Earnings ratio-0.41
Dividend yield
Dividend yield
Average volume
44.52M
Average volume44.52M
High today
$0.1095
High today$0.1095
Low today
$0.0853
Low today$0.0853
Open price
$0.0905
Open price$0.0905
Volume
7.96M
Volume7.96M
52 Week high
$7.84
52 Week high$7.84
52 Week low
$0.0853
52 Week low$0.0853

Stock Snapshot

With a market cap of 11.68M, China SXT Pharmaceuticals(SXTC) trades at $0.09. The stock has a price-to-earnings ratio of -0.41.

On 2026-01-21, China SXT Pharmaceuticals(SXTC) stock traded between a low of $0.09 and a high of $0.11. Shares are currently priced at $0.09, which is +7.7% above the low and -16.1% below the high.

China SXT Pharmaceuticals(SXTC) shares are trading with a volume of 7.96M, against a daily average of 44.52M.

During the past year, China SXT Pharmaceuticals(SXTC) stock moved between $0.09 at its lowest and $7.84 at its peak.

During the past year, China SXT Pharmaceuticals(SXTC) stock moved between $0.09 at its lowest and $7.84 at its peak.

People also own

Based on the portfolios of people who own SXTC. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.